Rheumatoid arthritis: Are FcRL4+ B cells the next target for RA biologic therapy?
Nicholas J
NJ
Bernard
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D001691:Biological Therapy; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D011961:Receptors, Fc / Q000378:metabolism*; D013583:Synovial Membrane / Q000378:metabolism / Q000473:pathology
D018501:Antirheumatic Agents; D016207:Cytokines; C423544:FCRL4 protein, human; D011961:Receptors, Fc